Translational Behavioral Medicine: a pathway to better health

HEALTH DETERMINANTS/HEALTH PRACTICES Isn’t it time to close the chasm between what we know about health determinants and what we put into practice to improve health [1]? Around the globe, 60% of all deaths are caused by chronic disease [2]. All parts of the world are affected. Eighty percent of chronic disease deaths now occur in lowand middle-income countries [2]. In the United States, nearly 50% of adults live with at least one chronic condition, and those conditions account for 75% of health care costs [3, 4]. The major causes of chronic disease — behavioral, psychosocial, and environmental influences on health— are the subject matter of behavioral medicine [1, 5]. Behavioral medicine is the interdisciplinary field concerned with integrating and applying psychosocial and biomedical knowledge to promote health, prevent disease, andmanage illness. Themission of Translational Behavioral Medicine (TBM), a new journal of the Society of Behavioral Medicine, is to advance the field’s knowledge and actualize it to improve individual and population health. TBM’s editorial board aims to accomplish this by bringing sound, actionable science to practitioners and catalyzing debate on policy issues that surround implementing the evidence. We know that people get sick because of unhealthy behaviors: a poor quality diet, physical inactivity, and tobacco use are the major risk factors for chronic disease around the globe. Eliminating those risks would make it possible to prevent at least 80% of heart disease, stroke, type 2 diabetes, and 40% of cancers [1, 6]. Adverse psychosocial influences, including depression and work stress, have just as negative effects on health, and they act separately from the harm produced by unhealthy behaviors [7]. We know that people get sicker or fail to recover because they don’t adhere to treatments. In fact, only about 50% of prescribed medications are actually taken [8, 9]. And yet, few countries spend very much money to address behavioral or psychosocial influences on health. The U.S., for example, allocates only 5% of its health care dollars to health promotion/disease prevention [5].

[1]  D. Marrero,et al.  Training YMCA Wellness Instructors to Deliver an Adapted Version of the Diabetes Prevention Program Lifestyle Intervention , 2009, The Diabetes educator.

[2]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997 .

[3]  A. Krämer,et al.  Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention , 2009, BMC public health.

[4]  G. Rose,et al.  Alcohol and Drugs: the Scottish Experience , 1993 .

[5]  Reneé H Moore,et al.  Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[6]  J. Mullahy Understanding the Production of Population Health and the Role of Paying for Population Health , 2010, Preventing chronic disease.

[7]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[8]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[9]  N. Teufel-Shone,et al.  Focus Groups in Small Communities , 2010, Preventing chronic disease.

[10]  P. Williams-Russo,et al.  The case for more active policy attention to health promotion. , 2002, Health affairs.

[11]  L. Sidossis,et al.  Lifestyle Intervention Favorably Affects Weight Loss and Maintenance Following Obesity Surgery , 2010, Obesity.

[12]  J. S. Cramer,et al.  An Adaptation of the Diabetes Prevention Program for Use With High-Risk, Minority Patients With Type 2 Diabetes , 2007, The Diabetes educator.

[13]  S. Yusuf,et al.  Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[14]  Timothy W. Smith,et al.  Invitation to a dialogue between researchers and clinicians about evidence-based behavioral medicine , 2005, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[15]  Alan D. Lopez,et al.  Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Volume 1. , 2004 .

[16]  David Haber,et al.  Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .

[17]  Leonard H Epstein,et al.  Family-based obesity treatment, then and now: twenty-five years of pediatric obesity treatment. , 2007, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[18]  A Keskinaslan,et al.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review , 2007, International journal of clinical practice.

[19]  E. Balas,et al.  Managing Clinical Knowledge for Health Care Improvement , 2000, Yearbook of Medical Informatics.

[20]  Michele Cecchini,et al.  Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness , 2010, The Lancet.

[21]  K. Bachman Obesity, weight management, and health care costs: a primer. , 2007, Disease management : DM.

[22]  Steven Baroletti,et al.  Medication Adherence in Cardiovascular Disease , 2010, Circulation.

[23]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997, JAMA.

[24]  Sheila Leatherman,et al.  The business case for quality: case studies and an analysis. , 2003, Health affairs.